Premium
Little Change in Functional Brain Networks Following Acute Levodopa in Drug‐Naïve Parkinson's Disease
Author(s) -
White Robert L.,
Campbell Meghan C.,
Yang Dake,
Shan William,
Snyder Abraham Z.,
Perlmutter Joel S.
Publication year - 2020
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.27942
Subject(s) - levodopa , parkinson's disease , placebo , functional magnetic resonance imaging , disease , medicine , drug , psychology , central nervous system disease , degenerative disease , physical medicine and rehabilitation , neuroscience , pharmacology , pathology , alternative medicine
Objective The objective of this study was to investigate the effects of levodopa on functional brain networks in Parkinson's disease. Methods We acquired resting state functional magnetic resonance imaging in 30 drug‐naïve participants with Parkinson's disease and 20 age‐matched healthy controls. Each participant was studied following administration of a single oral dose of either levodopa or placebo in a randomized, double‐blind, crossover design. Results The greatest observed differences in functional connectivity were between Parkinson's disease versus control participants, independent of pharmacologic intervention. By contrast, the effects of levodopa were much smaller and detectable only in the Parkinson's disease group. Moreover, although levodopa administration in the Parkinson's disease group measurably improved motor performance, it did not increase the similarity of functional connectivity in Parkinson's disease to the control group. Conclusions We found that a single, small dose of levodopa did not normalize functional connectivity in drug‐naïve Parkinson's disease. © 2019 International Parkinson and Movement Disorder Society